# 6-Month Phase I/II Open Label PRTX-100 in Previous Rheumatoid Arthritis Study Participants and Sera Collection

> **NCT02330445** · PHASE1,PHASE2 · COMPLETED · sponsor: **Protalex, Inc.** · enrollment: 13 (actual)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **DRUG:** PRTX-100

## Key facts

- **NCT ID:** NCT02330445
- **Lead sponsor:** Protalex, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2016-04-18
- **Final completion:** 2016-11-30
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2018-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02330445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02330445, "6-Month Phase I/II Open Label PRTX-100 in Previous Rheumatoid Arthritis Study Participants and Sera Collection". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02330445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*